BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24875360)

  • 1. Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction.
    Liu X; Xue R; Ji L; Zhang X; Wu J; Gu J; Zhou M; Chen S
    Biochem Biophys Res Commun; 2014 Jul; 450(1):117-23. PubMed ID: 24875360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
    Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
    Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S; Wang J; Liu Q; Harnish DC
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.
    Volynets V; Spruss A; Kanuri G; Wagnerberger S; Bischoff SC; Bergheim I
    J Lipid Res; 2010 Dec; 51(12):3414-24. PubMed ID: 20847296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
    Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
    Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
    Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amla prevents fructose-induced hepatic steatosis in ovariectomized rats: role of liver FXR and LXRα.
    Koshy SM; Bobby Z; Jacob SE; Ananthanarayanan PH; Sridhar MG; Paulose DT
    Climacteric; 2015 Apr; 18(2):299-310. PubMed ID: 24940994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.
    Haub S; Kanuri G; Volynets V; Brune T; Bischoff SC; Bergheim I
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G335-44. PubMed ID: 19713474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.
    Motomura W; Inoue M; Ohtake T; Takahashi N; Nagamine M; Tanno S; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1111-8. PubMed ID: 16403437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
    Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
    Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats.
    Song M; Schuschke DA; Zhou Z; Zhong W; Zhang J; Zhang X; Wang Y; McClain CJ
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(11):G934-45. PubMed ID: 25813056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice.
    Xiong X; Wang X; Lu Y; Wang E; Zhang Z; Yang J; Zhang H; Li X
    J Hepatol; 2014 Apr; 60(4):847-54. PubMed ID: 24333182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.